Trial intelligence / Profile preview

Botulinum toxin A and facial anesthetic infiltration for tinnitus intensity in temporomandibular disorders

RBR-73jdz5Recruiting

Sponsor
Hospital Universitário Professor Edgard Santos
Start
Jan 2018
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Double-blind trial of botulinum toxin type A, lidocaine and sodium chloride in temporomandibular disorder (TMD) and tinnitus, sponsored by Hospital Universitário Professor Edgard Santos. Started Jan 2018; status: recruiting.

02

Drugs

botulinum toxin type Alidocainesodium chloride
03

Conditions

temporomandibular disorder (TMD)tinnitus

Beyond the preview

Go deeper on RBR-73jdz5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-73jdz5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call